Background-Plasma levels of high-density lipoprotein cholesterol (HDL-C) are known to be heritable, but only a fraction of the heritability is explained. We used a high-density genotyping array containing single-nucleotide polymorphisms (SNPs) from HDL-C candidate genes selected on known biology of HDL-C metabolism, mouse genetic studies, and human genetic association studies. SNP selection was based on tagging SNPs and included low-frequency nonsynonymous SNPs. Methods and Results-Association analysis in a cohort containing extremes of HDL-C (case-control, nϭ1733) provided a discovery phase, with replication in 3 additional populations for a total meta-analysis in 7857 individuals. We replicated the majority of loci identified through genome-wide association studies and present on the array (including ABCA1
concentration is associated with decreased risk of atherosclerotic cardiovascular disease independent of low-density lipoprotein cholesterol concentration. 1 The HDL particle comprises phospholipid, cholesterol, triglyceride, and a variety of proteins 2 and is believed to exert its antiatherosclerotic effects through a process called reverse cholesterol transport, where the HDL particle promotes the efflux of cholesterol from extrahepatic tissues and cells (particularly macrophages) and delivers it to the liver for excretion in the bile. 3 The HDL particle is generated, matured, and catabolized 4 through a complex series of processes presenting many discrete biological steps at which genetic perturbations could profoundly affect HDL concentration. Although the heritability of HDL-C concentration is estimated at Ϸ50%, 5 the precise genetic players and the extent to which each of these factors affects HDL-C concentration in the general population is largely unknown.
including HDL-C. 6 Many of the identified loci contain genes previously implicated in lipid metabolism either through identified Mendelian disorders of lipid metabolism or by biochemical and cell biology investigations of lipid metabolism. GWAS also have identified novel loci that may elucidate previously unsuspected pathways that regulate lipid metabolism. However, the commercially available GWAS platforms suffer from uneven genomic SNP coverage, and SNP coverage in some of the HDL-C candidate genes is particularly poor. In addition, they are designed to assay a sample of common single-nucleotide polymorphisms (SNPs) (minor allele frequency [MAF] Ͼ0.05) across the entire genome rather than to provide comprehensive, dense genotyping, including low-frequency variants. Furthermore, all GWAS to date have been performed in subjects unselected on the basis of lipid traits. Population-based resequencing studies of HDL-C candidate genes have suggested that both common and rare associated variants are concentrated in subjects at the extremes of the HDL-C distribution, 7, 8 suggesting that studies in subjects from the extremes of the HDL-C distribution may be more powerful than similarly sized population cohorts, particularly for identifying lowfrequency variants associated with the HDL-C phenotype.
HDL-C candidate gene studies have been performed previously, looking at a variable number of HDL-C candidate genes. 9 For many of these studies, subsequent studies to replicate their results have failed. Lack of replication likely is due to multiple causes, including studying a limited number of variants in the candidate genes and small sample sizes, with many of the studies analyzing different variants for the same candidate genes. 9, 10 To address these concerns, we participated in a collaboration among the University of Pennsylvania (UPenn) Institute of Translational Medicine and Therapeutics (ITMAT); the Broad Institute; and the National Heart, Lung, and Blood Institute-supported Candidate-Gene Association Resource (CARe) Consortium to develop the ITMAT-Broad-CARe (IBC) cardiovascular gene array 11 using Illumina Infinium technology. 12, 13 This array was designed to include 66 HDL-C candidate gene loci (online-only Data Supplement Table 1 ). Candidate genes were chosen on the basis of known biology of HDL metabolism, data from mouse genetic studies, published human genetic association studies, and the first reports of lipid-related GWAS data. The IBC cardiovascular gene array also included low-frequency and rare nonsynonymous variants with potential phenotypic consequences.
We used an extreme HDL-C case-control study design as a discovery cohort to assess association of 2415 SNPs in 66 HDL-C candidate genes and replicated our findings in 3 cohorts comprising subjects unselected on the basis of lipid traits. The dense SNP coverage of candidate genes on the IBC array and the inclusion of low-frequency nonsynonymous variants enabled us to identify multiple nonsynonymous SNPs in candidate genes with suggestive evidence of association with HDL-C and that may help to explain the association signal. Additionally, we were able to identify several genes with multiple, independent SNPs significantly associated with HDL-C.
Methods

Subjects
Discovery Cohort
The UPenn HDL Case-Control study comprises subjects with extreme levels of HDL-C who were recruited through the hospital of the UPenn clinical laboratory. The UPenn Institutional Review Board approved the study protocol. The UPenn Catheterization cohort comprises consecutive subjects undergoing coronary angiography at UPenn Health System hospitals and has been previously described. 14 In the present study, unrelated subjects of European ancestry with HDL Ͼ90th percentile for age and sex were analyzed as cases (nϭ695), and subjects with HDL Ͻ30th percentile for age and sex were analyzed as controls (nϭ1038).
Three Replication Cohorts
The UPenn Replication Cohort (Penn-RC), the Monitoring of Trends and Determinants in Cardiovascular Disease/Cooperative Health Research in the Region of Augsburg (MONICA/KORA) Augsburg study, and the Genetic Regulation of Arterial Pressure of Humans in the Community (GRAPHIC) study were used for replication analysis. Genotypes and HDL-C were available for up to 2752 Penn-RC subjects, 1544 MONICA/KORA Augsburg subjects, and 2020 GRAPHIC subjects. Each study's respective institutional review board approved the study protocols, and informed consent was obtained from all subjects.
Statistical Analyses
Genotypes were obtained using the HumanCVD BeadChip (Illumina). For quality control, we eliminated SNPs with a genotype call rate Ͻ95%, with MAFϽ0.01 in Penn-RC controls, or with a significant departure from Hardy-Weinberg equilibrium (PϽ1ϫ10 Ϫ6 in combined cases and controls). We also eliminated individuals with Ͻ97.5% of the array SNPs successfully genotyped. Table 1 .
Table 2. Most Significant SNP for Each Candidate Locus in Meta-Analysis
*Nonsynonymous SNP.
The discovery cohort was analyzed using a case-control design and multiple logistic regression to test the association of each SNP. The replication cohorts were analyzed with multiple linear regression to test the association of each SNP with HDL-C after adjusting for age and sex under an additive model of inheritance. All analyses were conducted using PLINK software. 15 All candidate gene SNPs were tested in the replication cohorts. Each study was analyzed separately, and to summarize the data, a meta-analysis was implemented using METAL software, 16 which uses the P value and the direction of the effect to calculate a z statistic. Individual z statistics were combined in an overall z statistic, which was calculated as a weighted sum of each of the individual study z statistics (where weights were proportional to the square root of the number of individuals examined in each sample and selected such that the squared weights sum to 1). The corresponding P value was then calculated. A P value significance threshold of Ͻ2.03ϫ10 Ϫ5 in the meta-analysis was determined based on the conservative Bonferroni correction (0.05/2459 tests), and a PϽ0.05 suggested an association with HDL-C.
Conditional analyses were performed by incorporating genotypes of the most significantly associated SNP from each associated locus as covariates simultaneously in the association analyses to identify any residual association signal from additional independent SNPs associated with HDL-C. The conditional analysis was performed as a forward step-wise regression, adding the genotypes of the highest remaining associated SNPs in each locus as covariates in an iterative process until there was no longer any evidence of association with HDL. This analysis was performed using a gene-based Bonferroni correction for the total number of candidate genes tested (0.05/66 genes, PϽ7.6ϫ10 Ϫ4 ). Each study was analyzed separately, and the data were summarized using the METAL software. 16 Additional information is available in the online-only Data Supplement Methods.
Results
Extreme Case-Control Discovery
A total of 2415 SNPs were analyzed for 66 candidate genes in a case-control cohort comprising individuals from the extremes of the HDL-C phenotypic distribution (Table 1) . After removing very-low-frequency (MAF Ͻ0.01 in controls) and poorly performing SNPs, 31 SNPs from 3 candidate genes (CETP, LIPG, LPL) reached the threshold for significance in the discovery data set based on the conservative Bonferroni correction (0.05/2415 SNPs, PϽ2.1ϫ10 Ϫ5 ). An additional 293 SNPs from 39 further candidate genes suggested evidence of association (uncorrected PϽ0.05) (onlineonly Data Supplement Table 2 ).
Replication Study
Because the association of these SNPs was identified through a case-control cohort ascertained from the extremes of a quantitative trait, an attempt was made to replicate these results in the following 3 cohorts unselected on the basis of lipid traits to verify that these SNPs are associated with the quantitative trait of HDL-C: 1 US cohort of individuals of European descent (Penn-RC) and 2 European cohorts (MONICA/KORA and GRAPHIC). We analyzed the 324 SNPs with suggestive or significant evidence of association in the case-control discovery cohort (uncorrected PϽ0.05). Results from the replication cohorts were combined using the METAL software (individual cohort and the combined replication analysis results are available in online-only Data Supplement Table 2 ). All 31 of the SNPs reaching the threshold for significance in the discovery cohort were replicated at a significance threshold of PϽ0.05 in the combined replication analysis, and 40 SNPs from 4 genes (CETP, LPL, APOE, LIPC) were replicated with PϽ2.1ϫ10 Ϫ5 in the combined replication analysis.
Meta-Analysis
A meta-analysis was performed for the HDL candidate genes across all 4 cohorts (discovery and the 3 replication cohorts) in a total of 7857 subjects. Seventy-two SNPs from 6 candidate genes (APOE, CETP, FADS1/2/3, LIPC, LIPG, LPL) reached our Bonferroni-corrected level of significance (online-only Data Supplement Table 3 ). All of these candidate loci have been previously reported to be significantly associated with HDL-C. Of the 31 SNPs significantly associated in the discovery cohort, only 1 failed to reach the significance threshold in the meta-analysis (a CETP SNP, rs11076174; meta Pϭ1.0ϫ10 Ϫ4 ). Similarly, of the 72 SNPs significantly associated with HDL-C in the meta-analysis, only 1 did not exhibit suggestive association in the discovery cohort (an LIPC SNP, rs261338; meta-analysis Pϭ1.27ϫ10 Ϫ5 ; UPenn HDL Case-Control study, Pϭ0. 16) . A total of 374 SNPs in 42 candidate genes had suggestive evidence of association after meta-analysis (PϽ0.05) (onlineonly Data Supplement Table 3 ). The most significant SNP for each candidate gene with at least 1 SNP exhibiting a PϽ0.01 is presented in Table 2 . Notably, the most significantly 
Genotypes of the most significantly associated SNP from each of the top 14 loci were included as covariates in the association analysis: rs17231506 (CETP), rs264 (LPL), rs2156552 (LIPG), rs2075650 (APOE/C1/C2), rs174570 (FADS1/2/3), rs588136 (LIPC), rs12287066 (APOA1/A4/A5/C3), rs914189 (ABCG1), rs1801695 (APOB), rs3905001 (ABCA1), rs3922628 (GPR109A/B/81), rs838878 (SCARB1), rs7493 (PON1/2/3/4), and rs3774964 (NFKB1). D indicates direction. Other abbreviations as in Table 2 .
associated SNP for several of the loci (APOA5, APOB, PON2, LRP2) were nonsynonymous variants I44M (rs12287066), A4481T (rs1801695), S311C (rs7493), and G669D (rs34291900), respectively. In addition, many of the candidate genes had nonsynonymous SNPs associated with HDL-C, although these SNPs may not have been the most significantly associated SNP. Online-only Data Supplement  Table 4 lists all the nonsynonymous SNPs in the candidate genes suggestively associated with HDL-C (PϽ0.05).
Many of the most significant SNPs associated with HDL-C in first-generation GWAS were included on the IBC array. A few additional SNPs from late first-generation GWAS were included on the second version of the IBC array, which was genotyped in only 1 of the subcohorts of Penn-RC, the UPenn Coronary Artery Calcification cohort. Previous GWAS SNPs were examined in all cohorts and in the meta-analysis (online-only Data Supplement Table 5 ). We replicated 47 of 65 testable SNPs, and 17 of 28 testable loci at PϽ0.05, including the recently reported loci near the LILRA3, LRP4, SCARB1, TRIB1, and ZNF648 genes. 6
Conditional Analyses
We used a forward step-wise regression analysis to identify additional independent association signals at the most significantly associated loci. Using a gene-based Bonferroni correction for the total number of candidate genes tested (0.05/66 genes, PϽ7.6ϫ10 Ϫ4 ), 14 candidate loci contained SNPs associated with HDL-C. Genotypes of the most significantly associated SNPs from each of these 14 loci were simultaneously included as covariates in the association analyses. Additional independently associated SNPs were identified, and their genotypes were included as covariates in the association analyses in an iterative process to identify all the independently associated SNPs in these 14 loci. Five of the candidate gene loci had evidence of multiple independent HDL-C association signals, sometimes with the minor alleles of the independently associated SNPs having opposite directions of effect (Table 3, Figure) . Combining the 22 independent SNPs identified in this manner, the proportion of variance of HDL-C explained was 6.4% in Penn-RC, 8.2% in MONICA/KORA, and 8.0% in the GRAPHIC founders, or Ϸ13% to 16% of the heritability was explained.
Discussion
The present study represents a comprehensive candidate gene approach to identifying loci affecting HDL-C in humans, genotyping genes selected based on known biology of HDL metabolism, data from mouse studies, published genetic association studies, and available first-generation GWAS data (online-only Data Supplement Table 1 ). An extreme HDL phenotype case-control cohort was used for discovery purposes, with extensive replication in populations unselected for lipids. We also used these studies to perform a meta-analysis of Ͼ7800 individuals. The extreme case-control discovery cohort design for the quantitative trait HDL-C appeared to efficiently identify associated SNPs. All 31 SNPs reaching the significance threshold in the discovery cohort replicated at a significance threshold of PϽ0.05, and all but 1 were significantly associated in the meta-analysis. All of the 40 SNPs significantly associated with HDL-C in the combined quantitative trait locus analysis using studies unselected for lipids (used in this article to replicate the discovery cohort results) were at least suggestively associated in the discovery cohort. Similarly, only 1 of 72 total SNPs reaching the significance threshold after meta-analysis failed to be even nominally associated in the discovery cohort. Additionally, cohorts comprising extreme cases may be ideally suited for identifying low-frequency, causative alleles of large effect in candidate loci when such alleles are adequately represented. The IBC array allowed higher-density genotyping than com-mercially available genome-wide platforms with targeted coverage of candidate genes and an emphasis on potentially functional coding variants.
Several of the HDL-C GWAS loci reported to date are replicated here, and suggestive evidence for an association with HDL-C for several additional candidate genes is provided, many of which have not been reported in GWAS to date and may be poorly covered on commercially available platforms. 11 Prior candidate gene studies have explored many of these loci with variable results likely because of small sample sizes and limited genotyping. 9, 10 Interest in these loci persists because of compelling biological and animal data, such as for ABCG1, GPR109A, and PCSK5. ABCG1 knockout mice exhibit decreased HDL-C on a high-fat diet and ABCG1 has been shown to mediate cholesterol efflux to HDL. 17, 18 GPR109A has been shown to be the receptor for nicotinic acid, 19 which is used clinically to raise HDL-C levels. PCSK5 is a proprotein convertase that has been shown to modulate HDL-C levels through inactivation of endothelial lipase. 20, 21 A genetic variant in PCSK5 also was recently shown to segregate with low HDL-C in a human pedigree. 22 Evidence also exists for multiple independent associations with HDL-C within 5 loci (CETP, LPL, LIPG, APOA1/A4/ A5/C3, ABCA1), consistent with the findings published by Talmud et al 23 using the same IBC array. They identified multiple independent associations with HDL-C in CETP, LPL, LIPC, and APOA5. A recent meta-analysis of 46 lipid GWAS also identified 6 HDL-C loci with at least a second independent association with HDL-C, including LPL, ABCA1, APOA1/A4/A5/C3, ZNF664, LIPC, and CETP. 6 We note in the present study that the minor alleles of the SNPs that are independently associated may have effects in opposite directions and suggest that genes harbor multiple causative variants across the frequency spectrum from common to rare variants. As an example, we replicated the previously published finding in the endothelial lipase gene LIPG, show- ing that common SNPs 3Ј to the gene and the low-frequency nonsynonymous variant N396S (rs77960347) independently associate with HDL-C. 8 The 3Ј SNPs may affect transcript levels, whereas the N396S variant has been shown to have reduced phospholipase activity in vitro and in vivo. 8 It is also possible that a single locus may harbor Ͼ1 causative gene, which may be the case at the APOA1/A4/ A5/C3 locus. We identified 2 independent signals in the region: 1 being the APOA5 nonsynonymous variant I44M (rs12287066) and 1 being a noncoding SNP nearer APOA1 (rs12099358) ( Figure D) . Interestingly, meta-analysis of 46 GWAS also identified 2 independent SNPs in the locus, with the first SNP near APOA5 and the second SNP near APOA1. Furthermore, Chasman et al 24 showed that triglyceride phenotype associations accumulate near APOA5, but HDLrelated phenotypic associations predominate near APOA1, suggesting 2 independent effects at the locus from possibly 2 different genes.
The present analysis identified nonsynonymous variants as the most highly associated variants with HDL-C for APOA5, APOB, PON2, and LRP2 ( Table 2 ). We identified several other nonsynonymous variants that although not the SNP with the strongest evidence for association with HDL-C for the gene, may nonetheless have real and important effects on HDL-C levels. Specifically, 2 of our candidate loci (CETP and LIPG) harbor nonsynonymous variants significantly associated with HDL-C independent of the most significantly associated SNPs in the gene. It is possible that some of the other nonsynonymous SNPs identified in our study also are independently associated with HDL-C, but our study continues to be underpowered to detect the independent association. GWAS platforms emphasizing common variants (MAF Ͼ0.05) are likely to miss low-frequency nonsynonymous variants, which are difficult to impute because of their low frequency. The higher power (and larger numbers) needed to identify low-frequency causative variants suggest that even larger sample sizes analyzed on the IBC array may be able to identify rare nonsynonymous causative variants.
It is important to note that association, even of nonsynonymous variants, is not necessarily indicative of causality. The APOB SNP with the most significant HDL-C association in a meta-analysis of 46 GWASs was the nonsynonymous variant S4338N (rs1042034, MAFϭ0.22), 6 which is in strong linkage disequilibrium (r 2 ϭ0.98) with another nonsynonymous APOB variant, P2739R (rs676210, MAFϭ0.22), also significantly associated with HDL-C in the meta-analysis. Both variants are associated with HDL-C in the present study. The most significant APOB SNP in our study (A4481T, rs1801695, MAFϭ0.03) was unavailable in a majority of the 46 GWAS in the meta-analysis, even after imputation. Additional studies with these nonsynonymous variants will be necessary to determine which, if any, of these variants affect protein function and influence HDL-C.
In conclusion, this HDL-C candidate gene association study in Ͼ7800 individuals, using a dense genotyping array, provides evidence that a single locus associated with HDL-C may harbor multiple causative variants, sometimes with effects in opposite directions, and with various putative mechanisms of effect. The present study replicates many previously reported GWAS loci and provides suggestive evidence of association with HDL-C for several additional candidate genes. Furthermore, this study provides evidence that the extreme case-control discovery cohort design for studying quantitative traits can be efficiently used to identify associated SNPs.
